Cargando...
Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects
To evaluate the potential for ethnicity‐related differences in ataluren pharmacokinetics (PK) and safety, a phase 1 single‐dose study was conducted in 48 healthy (24 Japanese and 24 Caucasian subjects), nonsmoking male volunteers who were equally divided into 3 cohorts of oral doses at 5, 10, and 20...
Guardado en:
| Publicado en: | Clin Pharmacol Drug Dev |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590116/ https://ncbi.nlm.nih.gov/pubmed/30629861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.645 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|